Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam besylate for induction and maintenance of general anesthesia in ambulatory surgery
ChiCTR2300075899Phase 4Not yet recruiting
- Sponsor
- China Academy of Chinese Medical Sciences
- Start
- Nov 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of remimazolam and propofol in Conditions requiring general anesthesia for ambulatory surgery (2 arms), sponsored by China Academy of Chinese Medical Sciences. Primary endpoint: Proportion of successful induction and maintenance of anesthesia. Planned start Nov 2022; status: not yet recruiting.
02
Drugs
remimazolampropofol
03
Conditions
Conditions requiring general anesthesia for ambulatory surgery
Beyond the preview
Go deeper on ChiCTR2300075899.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300075899.